• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肥胖症手术腔内治疗(POSE)手术:患者一年的体重减轻情况及安全性结果。

The Primary Obesity Surgery Endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes.

作者信息

López-Nava Gontrand, Bautista-Castaño Inmaculada, Jimenez Amaya, de Grado Teresa, Fernandez-Corbelle Juan Pedro

机构信息

Bariatric Endoscopy Unit, Madrid Sanchinarro University Hospital, Madrid, Spain.

Bariatric Endoscopy Unit, Madrid Sanchinarro University Hospital, Madrid, Spain.

出版信息

Surg Obes Relat Dis. 2015 Jul-Aug;11(4):861-5. doi: 10.1016/j.soard.2014.09.026. Epub 2014 Oct 7.

DOI:10.1016/j.soard.2014.09.026
PMID:25701201
Abstract

BACKGROUND

Obesity is at epidemic proportions and increasing. Bariatric surgical procedures have demonstrated better durable weight loss than diet and exercise; however, risk may limit adoption of these procedures. Endoscopic procedures may offer less risk, lower cost, and satisfactory results, but limited safety and outcome data is available. The present report describes the Primary Obesity Surgery Endolumenal (POSE(™)) procedure, perioperative care, and 1-year safety and weight loss outcomes for a single center.

METHODS

One hundred forty-seven patients undergoing the POSE procedure between July 2011 and January 2013 were followed for 1 year. Overall patient status and weight data were collected at baseline and at 3, 6, and 12 months. Outcomes included change in total weight loss (TWL), percentage of TWL (%TWL), percentage of excess weight loss (%EWL), and adverse events.

RESULTS

Patients tolerated the procedure well with no serious short-term or long-term adverse events. All but 1 patient were discharged within 24 hours of the procedure. Baseline body mass index (BMI) was 38.0 ± 4.8 kg/m(2). Initial weight (106.8 ± 18.2 kg) was significantly reduced at 3, 6, and 12 months. At 1 year, 116 patients (79% of total) who were available for follow-up had a mean TWL of 16.6 ± 9.7 kg, %TWL of 15.1 ± 7.8, and %EWL of 44.9 ± 24.4.

CONCLUSION

After 1-year follow-up, POSE was considered an effective, safe and well tolerated procedure for the treatment of patients with obesity.

摘要

背景

肥胖呈流行趋势且不断增加。减肥手术已证明比饮食和运动能带来更持久的体重减轻;然而,风险可能会限制这些手术的采用。内镜手术可能风险更低、成本更低且效果令人满意,但可用的安全性和结果数据有限。本报告描述了单中心的原发性肥胖症手术腔内治疗(POSE(™))手术、围手术期护理以及1年的安全性和体重减轻结果。

方法

对2011年7月至2013年1月期间接受POSE手术的147例患者进行了1年的随访。在基线以及3、6和12个月时收集了患者的总体状况和体重数据。结果包括总体体重减轻(TWL)的变化、TWL百分比(%TWL)、超重减轻百分比(%EWL)以及不良事件。

结果

患者对该手术耐受性良好,无严重的短期或长期不良事件。除1例患者外,所有患者均在手术后24小时内出院。基线体重指数(BMI)为38.0±4.8kg/m²。初始体重(106.8±18.2kg)在3、6和12个月时显著降低。1年后,116例(占总数的79%)可进行随访的患者平均TWL为16.6±9.7kg,%TWL为15.1±7.8,%EWL为44.9±24.4。

结论

经过1年的随访,POSE被认为是治疗肥胖患者的一种有效、安全且耐受性良好的手术。

相似文献

1
The Primary Obesity Surgery Endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes.原发性肥胖症手术腔内治疗(POSE)手术:患者一年的体重减轻情况及安全性结果。
Surg Obes Relat Dis. 2015 Jul-Aug;11(4):861-5. doi: 10.1016/j.soard.2014.09.026. Epub 2014 Oct 7.
2
Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients.经口缝合术用于腔内垂直胃成形术的临床经验:64例患者的1年随访
Gastrointest Endosc. 2008 Jul;68(1):51-8. doi: 10.1016/j.gie.2007.10.061. Epub 2008 Mar 19.
3
Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome.经口胃旁路术治疗病态肥胖:一项为期 1 年的多中心试验结果。
Gastrointest Endosc. 2011 Dec;74(6):1248-58. doi: 10.1016/j.gie.2011.08.046.
4
Comparison of results after one year between sleeve gastrectomy and gastric bypass in patients with BMI ≥ 50 kg/m².体重指数(BMI)≥50kg/m²的患者中,袖状胃切除术与胃旁路手术一年后结果的比较。
Surg Obes Relat Dis. 2015 Jul-Aug;11(4):785-90. doi: 10.1016/j.soard.2014.11.022. Epub 2014 Dec 4.
5
Endoscopic management of obesity: Impact of endoscopic sleeve gastroplasty on weight loss and co-morbidities at six months and one year.肥胖症的内镜治疗:内镜袖状胃成形术对6个月和1年时体重减轻及合并症的影响
J Visc Surg. 2023 Apr;160(2S):S38-S46. doi: 10.1016/j.jviscsurg.2022.12.003. Epub 2023 Jan 30.
6
Long-Term outcomes and experience of laparoscopic adjustable gastric banding: one center's results in China.腹腔镜可调节胃束带术的长期疗效及经验:中国某中心的结果
Surg Obes Relat Dis. 2015 Jul-Aug;11(4):855-9. doi: 10.1016/j.soard.2014.09.021. Epub 2014 Oct 8.
7
Long-term results of adjustable gastric banding in a cohort of 186 super-obese patients with a BMI≥ 50 kg/m2.186 例 BMI≥50kg/m2 的超级肥胖患者接受可调胃束带术的长期结果。
J Visc Surg. 2012 Apr;149(2):e143-52. doi: 10.1016/j.jviscsurg.2012.01.007. Epub 2012 Mar 2.
8
Mean fourteen-year, 100% follow-up of laparoscopic adjustable gastric banding for morbid obesity.腹腔镜可调胃束带术治疗病态肥胖症的 14 年、100%随访结果。
Surg Obes Relat Dis. 2013 Sep-Oct;9(5):753-7. doi: 10.1016/j.soard.2013.05.010. Epub 2013 Jun 14.
9
Comparison of laparoscopic sleeve gastrectomy to laparoscopic Roux-en-Y gastric bypass for morbid obesity in a military institution.腹腔镜袖状胃切除术与腹腔镜 Roux-en-Y 胃旁路术治疗军队机构中病态肥胖的比较。
Surg Obes Relat Dis. 2014 Mar-Apr;10(2):269-76. doi: 10.1016/j.soard.2012.08.012. Epub 2012 Aug 30.
10
Endoscopic sleeve gastroplasty in the management of overweight and obesity: an international multicenter study.内镜袖状胃成形术治疗超重和肥胖:一项国际多中心研究。
Gastrointest Endosc. 2019 Nov;90(5):770-780. doi: 10.1016/j.gie.2019.06.013. Epub 2019 Jun 19.

引用本文的文献

1
Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review.减重手术和内镜治疗对代谢功能障碍相关脂肪性肝病肝脏健康的影响:综述
J Clin Med. 2025 Jun 6;14(12):4012. doi: 10.3390/jcm14124012.
2
Endoscopic Bariatric Therapy for Obesity and Metabolic Syndrome.肥胖症和代谢综合征的内镜减肥治疗
Korean J Helicobacter Up Gastrointest Res. 2023 Dec;23(4):247-253. doi: 10.7704/kjhugr.2023.0049. Epub 2023 Dec 8.
3
Endoscopic Sleeve Gastroplasty: A Retrospective Cohort Study of 90 Patients in Colombia.
内镜下袖状胃成形术:对哥伦比亚90例患者的回顾性队列研究
Obes Surg. 2025 May 29. doi: 10.1007/s11695-025-07945-y.
4
The POSE-2 Procedure for People with Obesity: A Safe and Effective Treatment Option.POSE-2 肥胖症治疗程序:安全有效的治疗选择。
Obes Surg. 2024 Oct;34(10):3686-3693. doi: 10.1007/s11695-024-07488-8. Epub 2024 Sep 5.
5
Update on Endoscopic Treatments for Obesity.肥胖症内镜治疗的最新进展
Curr Obes Rep. 2024 Jun;13(2):364-376. doi: 10.1007/s13679-024-00551-6.
6
Endobariatrics: a Still Underutilized Weight Loss Tool.内镜减重术:一种仍未得到充分利用的减肥工具。
Curr Treat Options Gastroenterol. 2023;21(2):172-184. doi: 10.1007/s11938-023-00420-6. Epub 2023 May 6.
7
Endoscopic bariatrics: current therapies and future directions.内镜减重治疗:当前疗法与未来方向。
Transl Gastroenterol Hepatol. 2022 Apr 25;7:21. doi: 10.21037/tgh.2020.03.09. eCollection 2022.
8
Endoscopic Bariatric Therapies: Current Status and Future Perspectives.内镜减重治疗:现状与未来展望。
JSLS. 2022 Jan-Mar;26(1). doi: 10.4293/JSLS.2021.00066.
9
Review about Psychological Barriers to Lifestyle Modification, Changes in Diet Habits, and Health-Related Quality of Life in Bariatric Endoscopy.减重内镜治疗中心生活方式改变、饮食行为变化和健康相关生活质量的心理障碍综述
Nutrients. 2022 Jan 29;14(3):595. doi: 10.3390/nu14030595.
10
A Mediterranean-Style Diet Plan Is Associated with Greater Effectiveness and Sustainability in Weight Loss in Patients with Obesity after Endoscopic Bariatric Therapy.地中海饮食计划与内镜减重治疗后肥胖患者减肥的有效性和可持续性增加相关。
Medicina (Kaunas). 2022 Jan 22;58(2):168. doi: 10.3390/medicina58020168.